Moderna Producing Booster Shots for Covid-19 Variants
Moderna plans to produce a new version of their Covid-19 vaccine in an attempt to target the South African Strain. The shot will be a booster shot aiming to protect against new strains of coronavirus, and some doses have already been sent to the NIH for a clinical study.
In addition to this, Moderna is also testing a third shot of their existing vaccine, another booster, and they plan to test a booster shot combining the new vaccine for the South African strain and their existing vaccine.
Clinical studies for all of these shots will be done at the NIH. Tal Zaks, Moderna’s chief medical officer said, “We want to make sure that people are immune in the long run both against the ancestral strain, which may or may not require a third dose, and against what could be an emerging variant of concern.”
Moderna Chief Executive Officer Stephane Bancel said, “Moderna is committed to making as many updates to our vaccine as necessary until the pandemic is under control. We hope to demonstrate that booster doses, if necessary, can be done at lower dose levels, which will allow us to provide many more doses to the global community in late 2021 and 2022 if necessary.”
The company has so far estimated that it has delivered about 60 million covid-19 vaccine doses globally and another 33 million have been produced. For more updates be sure to check back with the ABN Blog regularly.